Transthyretin amyloidosis: A new mutation associated with dementia

Annals of Neurology

Volumn 41, Issue 3, 1997, Pages 307-313

  Petersen, R B ^a,e   Goren, H ^c   Cohen, M ^a   Richardson, S L ^a   Tresser, N ^d   Lynn, A ^b   Gali, M ^a   Estes, M ^c   Gambetti, P ^a,e  

^a Institute of Pathology   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; DNA; PREALBUMIN;

ADULT; AMINO ACID SUBSTITUTION; AMYLOIDOSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DEMENTIA; DNA DETERMINATION; FAMILIAL DISEASE; FAMILY STUDY; FEMALE; GENE MUTATION; GENETIC LINKAGE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROPATHOLOGY; PEDIGREE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL;

AMYLOID NEUROPATHIES; ATROPHY; BRAIN; CEREBELLUM; CEREBRAL CORTEX; DEMENTIA; EYE; GENES, DOMINANT; HUMANS; LINKAGE (GENETICS); MIDDLE AGED; MUSCLE, SKELETAL; PEDIGREE; PERIPHERAL NERVES; PHENOTYPE; POINT MUTATION; PREALBUMIN; VISCERA;

EID: 0031055128     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410410305     Document Type: Article

References (26)

1. Ghiso J, Wisniewski T, Frangione B. Unifying features of systemic and cerebral amyloidosis. Mol Neurobiol 1994;8:49-64
2. Hamilton JA, Steinrauf LK, Liepnieks J, et al. Alteration in mo-lecular structure which results in disease: the Met-30 variant of human plasma transthyretin. Biochem Biophys Acta 1992;1139:9-16
3. Benson MD. Amyloidosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. Metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw-Hill, 1995:4159-4191
4. Saraiva MJM. Transthyretin mutations in health and disease. Hum Mutat 1996;5:191-196
5. Benson MD. Leptomeningeal amyloid and variant transthyretins. Am J Pathol 1996;148:351-354
6. Goren J, Steinberg M, Farboody GH. Familial oculoleptomeningeal amyloidosis. Brain 1980;103:473-495
7. Uitti RJ, Donat JR, Rozdilsky B, et al. Familial oculoleptomeningeal amyloidosis. Report of a new family with unusual features. Arch Neurol 1988;45:1118-1122
8. Vidal R, Garzuly F, Budka H, et al. Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD18G). Am J Pathol 1996;148:361-366
9. Petersen RB, Tresser NJ, Richardson SL, et al. A family with oculoleptomeningeal amyloidosis and dementia has a mutation in the transthyretin gene. J Neuropathol Exp Neurol 1995;54: 413 (abstract)
10. Kim KS, Kwang S, Miller DL, et al. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci Res Commun 1988;2:121-130
11. Sternberger LA. Staining for light microscopy. In: Immunocytochemistry. 3rd ed. New York: Wiley, 1986:122-127
12. Nichols WC, Gregg RE, Brewer HB, Benson MD. A mutation in apolipoprotein A-1 in the Iowa type of familial amyloidotic polyneuropathy. Genomics 1990;8:318-323
13. Lathrop GM, Lalouel C, Julier C, Ott J. Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA 1984; 81:3443-3446
14. Herbert J, Younger D, Latov N, Martone RL. Clinical spectrum of familial amyloidotic polyneuropathy. In: Kisilevsky R, Benson M, Frangione B, et al, eds. Amyloid and amyloidosis 1993. New York: Parthenon Publishing, 1994:486-488
15. Hamburg A. Unusual cause of vitreous opacities: primary familial amyloidosis. Ophthalmologica 1971;162:173-177
16. Okayama M, Goto I, Ogata J, et al. Primary amyloidosis with familial vitreous opacities. Arch Intern Med 1978;138:105-111
17. Terry CJ, Damas AM, Oliveira P, et al. Structure of Met30 variant of transthyretin and its amyloidogenic implications. EMBO J 1993;12:735-741
18. Hamilton JA, Steinrauf LK, Braden BC, et al. The x-ray crystal structure refinements of normal human transthyrerin and the amyloidogenic Val-30 to Met variant to 1.7A resolution. J Biol Chem 1993;268:2416-2424
19. Jones AL, Skare J, Cohen AS, et al. Familial amyloidotic polyneuropathy: a new transthyretin position 30 mutation (alanine for valine) in a family of German descent. Clin Genet 1992;41:70-73
20. Benson MD, Cohen AS. Generalized amyloid in a family of Swedish origin. Ann Intern Med 1977;86:419-424
21. 55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvement. Hum Genet 1992;89:353-356
22. Koeppen AH, Wallace MR, Benson MD, Altland K. Familial amyloid polyneuropathy: alanine-for-threonine substitution in the transthyretin (prealbumin) molecule. Muscle Nerve 1990; 13:1065-1075
23. Koeppen AH, Mitzen EJ, Hans MB, et al. Familial amyloid polyneuropathy. Muscle Nerve 1985;8:733-749
24. Izumoto S, Younger D, Hays AP, et al. Familial amyloidotic polyneuropathy presenting with carpal tunnel syndrome and a new transthyretin mutation, asparagine 70. Neurology 1992;42: 2094-2102
25. Ueno S, Fujimura H, Yorifuji S, et al. Familial amyloid polyneuropathy associated with the transthyretin Cys114 gene in a Japanese kindred. Brain 1992;115:1275-1289
26. Reilly MM, Adams D, Booth DR, et al. Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy. Brain 1995;118:849-856